Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

M50054 may help treat hepatitis and hair loss from chemotherapy.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

CD133+ cells are crucial for hair growth.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

New mouse models help study melanocytic cells for melanoma research.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

γδ T cells are crucial for early wound healing after a skin virus infection.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

A new genetic mutation causing Xeroderma Pigmentosum was found in an 8-year-old girl, affecting her DNA repair.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Antibodies help identify glycoproteins in normal skin and tumor cells.

pCLCA2 protein may help maintain skin structure and function.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

A new mutation in the CDH3 gene causes hair loss and vision problems in a young girl.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

CS12192 effectively treats alopecia areata with better safety than current options.